Article Details

BridgeBio Pharma (NASDAQ:BBIO) PT Lowered to $80.00 at The Goldman Sachs Group

Retrieved on: 2021-05-13 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

BridgeBio Pharma (NASDAQ:BBIO) PT Lowered to $80.00 at The Goldman Sachs Group. View article details on hiswai:

Excerpt

The brokerage currently has a "buy" rating on the stock. The Goldman Sachs Group's target price points to a potential upside of 61.68% from the ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up